Cardiology (all articles)
New Observational Studies Confirm the Safety of Renin–Angiotensin–Aldosterone System Blockers in Patients with Covid-19
3 May, 2020 | 22:32h | UTCStudy 3: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 – New England Journal of Medicine
Commentary: Blood Pressure Drugs Don’t Increase Coronavirus Risk, Studies Find – The New York Times
See also: Observational Study: Renin-Angiotensin System Inhibitors are Not Associated with Severity or Mortality in Hospitalized Patients with Coronavirus Disease (2 other studies on the subject)
Case Series: QT Intervals in Patients with COVID-19 Treated with Hydroxychloroquine Alone or in Combination with Azithromycin
3 May, 2020 | 22:01h | UTCCommentary: Beth Israel Deaconess Medical Center – Beth Israel Deaconess Medical Center
Related Studies: The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection – Circulation: Arrhythmia and Electrophysiology (link to abstract – $ for full-text) AND [Preprint] QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin – medRxiv
[Abstract Only] Cohort Study: Effect of Hydroxychloroquine and Azithromycin on the QT Interval in Patients with Covid-19
1 May, 2020 | 03:10h | UTCThe Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection – Circulation: Arrhythmia and Electrophysiology (link to abstract – $ for full-text)
COVID-19 and the Cardiovascular System: Implications for Risk Assessment, Diagnosis, and Treatment Options
1 May, 2020 | 03:18h | UTCRelated Guidelines: COVID-19 rapid guideline: acute myocardial injury – National Institute for Health and Care Excellence AND ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic – European Society of Cardiology AND Management of Acute Myocardial Infarction During the COVID-19 Pandemic – Journal of the American Academy of Cardiology
AAN Recommendations for Closure of Patent Foramen Ovale in Secondary Stroke Prevention
1 May, 2020 | 02:34h | UTCNews Release: AAN updates recommendation on closure of common heart defect after stroke – American Academy of Neurology
Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy
30 Apr, 2020 | 04:19h | UTC
Evaluation and Management of Premature Ventricular Complexes
29 Apr, 2020 | 04:52h | UTCEvaluation and Management of Premature Ventricular Complexes – Circulation (free for a limited period)
Study: The QT Interval in Patients with COVID-19 Treated with Hydroxychloroquine and Azithromycin
26 Apr, 2020 | 21:18h | UTC
[Abstract Only] Randomized Trial: Clopidogrel Seems to Be a Better Choice for Patients > 70 years with Non-ST-elevation Acute Coronary Syndrome
26 Apr, 2020 | 21:14h | UTC
FDA Safety Alert: Risk of Heart Rhythm Problems with the use of Hydroxychloroquine or Chloroquine for COVID-19
26 Apr, 2020 | 21:20h | UTCNews Release: FDA warning for Hydroxychloroquine or Chloroquine for COVID-19: Risk of Heart Rhythm Problems – Outbreak News Today
NICE COVID-19 Rapid Guideline: Acute Myocardial Injury
24 Apr, 2020 | 03:50h | UTCRelated Guidelines: ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic – European Society of Cardiology AND Management of Acute Myocardial Infarction During the COVID-19 Pandemic – Journal of the American Academy of Cardiology
Observational Study: Renin-Angiotensin System Inhibitors are Not Associated with Severity or Mortality in Hospitalized Patients with Coronavirus Disease
24 Apr, 2020 | 03:46h | UTCCommentary: Drugs for high blood pressure don’t appear to make COVID-19 worse – Science News
‘Where Are All our Patients?’: Covid Phobia is Keeping People with Serious Heart Symptoms Away From ERs
24 Apr, 2020 | 03:26h | UTCRelated: Where Have All the Heart Attacks Gone? – The New York Times
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
23 Apr, 2020 | 09:27h | UTCCommentaries: Salt substitution could prevent almost half a million deaths from CVD in China – George Institute for Global Health AND Embracing salt substitutes could help China prevent 450K CVD deaths per year – Cardiovascular Business
Preoperative Evaluation Before Noncardiac Surgery
23 Apr, 2020 | 09:17h | UTCPreoperative Evaluation Before Noncardiac Surgery – Mayo Clinic Proceedings
Related Review: Preoperative Cardiac Risk Assessment (review and guidelines)
ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic
22 Apr, 2020 | 09:00h | UTC
ACC Consensus Statement: Management of Acute Myocardial Infarction During the COVID-19 Pandemic
21 Apr, 2020 | 08:17h | UTCCommentaries: ACC, SCAI, ACEP Release Consensus Statement on Management of AMI Patients During COVID-19 – American College of Cardiology
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
21 Apr, 2020 | 08:15h | UTCDescription and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome – Circulation
Randomized Trial: Twitter Promotion Increases Citation Rates of Cardiovascular Articles
21 Apr, 2020 | 07:53h | UTC
How Does Coronavirus Kill?
20 Apr, 2020 | 00:21h | UTC
Review: COVID-19 and Thrombotic or Thromboembolic Disease
20 Apr, 2020 | 00:18h | UTC
Priorities for Cath Labs in the COVID-19 Tsunami
20 Apr, 2020 | 00:15h | UTCCommentary: Priorities for Cath Labs in the COVID-19 Tsunami – American College of Cardiology
Related: Reperfusion of STEMI in the COVID-19 Era – Business as Usual? – Circulation AND As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI – TCTMD
The Science Underlying COVID-19: Implications for the Cardiovascular System
20 Apr, 2020 | 00:19h | UTCThe Science Underlying COVID-19: Implications for the Cardiovascular System – Circulation
Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic
20 Apr, 2020 | 00:14h | UTC
Observational Study: Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Seems Safe Among Patients with Hypertension Hospitalized With COVID-19
20 Apr, 2020 | 00:01h | UTC